European journal of anaesthesiology
-
Randomized Controlled Trial Comparative Study Clinical Trial
Small dose midazolam or droperidol reduces the hypnotic dose of propofol at the induction of anaesthesia.
We investigated the effect of a small dose of midazolam, ketamine, droperidol or lidocaine on the propofol dose required for hypnosis during induction of general anaesthesia. These drugs were randomly administered to 100 patients about to undergo scheduled surgery. Propofol was then infused at a rate of 250 microg kg-1 min-1 and the hypnotic dose to produce hypnosis was evaluated. ⋯ Only midazolam when compared with saline administration, (176 +/- 66 s and 298 +/- 126 s, respectively), shortened the time to achieve hypnosis. The changes in blood pressure (non-invasive) and heart rate were not significantly different in all groups during the induction of anaesthesia and oro-tracheal intubation. These results raise the possibility that new combinations of central nervous system drugs, such as droperidol and propofol, have a potential to reduce the dose of intravenous anaesthetics, including propofol, that produce hypnosis without significant adverse effects.
-
Randomized Controlled Trial Comparative Study Clinical Trial
Sevoflurane provides better recovery than propofol plus fentanyl in anaesthesia for day-care surgery.
To compare ease of maintenance and recovery characteristics of sevoflurane and propofol plus fentanyl in day-care anaesthesia, 60 outpatients undergoing elective surgery of up to 3 h duration were randomized to receive sevoflurane or propofol as their primary anaesthetic. Induction was always carried out with propofol, but a fentanyl bolus 5 microg kg-1 was added in the propofol group. ⋯ Patients treated with sevoflurane felt less confused, showed better performances in the digit symbol substitution test and achieved higher modified Aldrete scores sooner in the post-operative course. Maintenance of anaesthesia with sevoflurane produces faster emergence and recovery than propofol plus fentanyl after anaesthesia of short to intermediate duration.
-
Randomized Controlled Trial Clinical Trial
The influence of the alpha2-adrenoceptor agonist, clonidine, on the EEG and on the MAC of isoflurane.
We investigated the influence of intravenous clonidine 2, 4 and 6 microg kg-1 on the electroencephalogram and on the minimal alveolar concentration of isoflurane in 40 patients aged 20-60 years undergoing elective surgery. Minimal alveolar concentration was determined using the Dixon 'up-and-down' method. Thirty min after the clonidine infusion anaesthesia was induced with etomidate, 0.25 mg kg-1. ⋯ The minimal alveolar concentration of isoflurane decreased in a dose-dependent manner from 1.32% (95% CI, 1.28%-1.36%) in the control group to 1.03% (0.9%-1.18%) in patients given clonidine 6 microg kg-1. Clonidine 4 and 6 microg kg-1 was associated with a moderate reduction in heart rate and arterial systolic blood pressure. We recommend the use of clonidine intravenously as an adjunct to general anaesthesia in a dose of 4 microg kg-1 given 15 min before induction of anaesthesia.
-
Randomized Controlled Trial Clinical Trial
Brachial plexus block using a new subclavian perivascular technique: the proximal cranial needle approach.
We describe the proximal cranial needle approach for brachial plexus blockade; clear surface markings and cranial direction of the needle lead to satisfactory results with a low incidence of complications.
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
In a multicentre, randomized, double-blind, placebo-controlled dose-ranging study, 1030 patients undergoing outpatient surgery with general anaesthesia received i.v. dolasetron mesylate (12.5, 25, 50, or 100 mg) or placebo. The principal outcome measure was the proportion of patients who were free of emesis or rescue medication for the 24-h period after the study drug was given; the subsidiary outcome measure was survival time without rescue medication. Effects on nausea were quantified using a visual analogue scale. ⋯ No significant differences were observed in complete response for any dolasetron dose in males compared with placebo. The majority of adverse events reported were mild or moderate. Dolasetron provided well-tolerated, safe, and effective prophylaxis for post-operative nausea and vomiting with maximum effectiveness observed at a dose of 12.5 mg.